Demo Pharma Companies Trials 
H1 Blog
JUNE 7, 2023
Clinical trial success is a key factor for pharma companies when designing and recruiting patients into trials. This data can also provide guidance in terms of diversifying clinical trials to include different types of population demographics such as age, gender, race, ethnicity, or geographic location.
H1 Blog
JULY 30, 2024
Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
H1 Blog
DECEMBER 11, 2024
These forecasts highlight the key changes poised to transform the healthcare and pharma landscapes. In this edition, our CEO and co-founder, Ariel Katz, along with Regional VP of Trial Landscape, Ryan Brown, share their top predictions for 2025. Additionally, well see a move to multi-indication trials to maximize profitability.
H1 Blog
JULY 5, 2023
The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. African Americans).
Expert insights. Personalized for you.
52 
Let's personalize your content